Leonardo wins $2.5M grant for delivery tech

Leonardo Biosystems has won a $2.5 million grant from the Texas Emerging Technology Fund, a state financing initiative that is aimed at fostering life sciences companies. Leonardo is developing new delivery technology developed by Dr. Mauro Ferrari that targets delivery of siRNA and small molecule drugs. Leonardo release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.